Rafael Holdings, Inc. (NYSE:RFL) Sees Significant Drop in Short Interest

Rafael Holdings, Inc. (NYSE:RFLGet Free Report) was the target of a significant decline in short interest in January. As of January 31st, there was short interest totalling 78,500 shares, a decline of 23.2% from the January 15th total of 102,200 shares. Based on an average daily volume of 36,300 shares, the short-interest ratio is presently 2.2 days.

Rafael Trading Up 1.7 %

RFL traded up $0.04 during trading on Friday, hitting $2.09. The company had a trading volume of 26,968 shares, compared to its average volume of 33,304. The business has a 50-day moving average of $1.93 and a 200-day moving average of $1.81. Rafael has a 1-year low of $1.29 and a 1-year high of $2.50.

Rafael (NYSE:RFLGet Free Report) last posted its quarterly earnings results on Wednesday, December 11th. The company reported ($0.37) earnings per share (EPS) for the quarter. Rafael had a negative net margin of 5,707.03% and a negative return on equity of 53.71%.

Institutional Trading of Rafael

An institutional investor recently raised its position in Rafael stock. Geode Capital Management LLC raised its holdings in shares of Rafael Holdings, Inc. (NYSE:RFLFree Report) by 24.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 148,068 shares of the company’s stock after purchasing an additional 29,448 shares during the period. Geode Capital Management LLC owned about 0.60% of Rafael worth $287,000 as of its most recent SEC filing. Institutional investors and hedge funds own 11.30% of the company’s stock.

Rafael Company Profile

(Get Free Report)

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.

Featured Stories

Receive News & Ratings for Rafael Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rafael and related companies with MarketBeat.com's FREE daily email newsletter.